Qinglian Wen
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 9
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 13
- CAR-T cell therapy research 5
- Cancer Cells and Metastasis 4
- Immunology top 10%
- Molecular Biology top 10%
- RNA modifications and cancer 7
- Epigenetics and DNA Methylation 5
- Gut microbiota and health 4
-
- Endometrial and Cervical Cancer Treatments 6
- Co-authors
- Zhangang XiaoMingxing LiYueshui ZhaoJing ShenXu WuFukuan DuParham Jabbarzadeh KaboliJing Li
- Cited by
- Cancer ResearchOncologyImmunology
In The Last Decade
Qinglian Wen
61 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Cancer Research 423
- Oncology 534
- Immunology 327
- Molecular Biology 755
- Pulmonary and Respiratory Medicine 275
Countries citing papers authored by Qinglian Wen
This map shows the geographic impact of Qinglian Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinglian Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinglian Wen more than expected).
Fields of papers citing papers by Qinglian Wen
This network shows the impact of papers produced by Qinglian Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinglian Wen. The network helps show where Qinglian Wen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qinglian Wen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 12 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 5 | |
| 7 | 2022 | 20 | |
| 8 | 2022 | 20 | |
| 9 | 2022 | 31 | |
| 10 | 2022 | 27 | |
| 11 | 2021 | 16 | |
| 12 | 2021 | 18 | |
| 13 | 2021 | 26 | |
| 14 | 2020 | 44 | |
| 15 | 2020 | 37 | |
| 16 | 2019 | 23 | |
| 17 | 2019 | 15 | |
| 18 | 2019 | 121 | |
| 19 | 2018 | 3 | |
| 20 | 2016 | 24 |
About Qinglian Wen
Qinglian Wen is a scholar working on Oncology, Cancer Research and Obstetrics and Gynecology, having authored 67 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (13 papers), Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (7 papers), Endometrial and Cervical Cancer Treatments (6 papers), CAR-T cell therapy research (5 papers), Epigenetics and DNA Methylation (5 papers), Cancer Cells and Metastasis (4 papers) and Gut microbiota and health (4 papers). The work is most often cited by research in Cancer Research (423 citations), Oncology (534 citations) and Immunology (327 citations). Qinglian Wen has collaborated with scholars based in China, Hong Kong and Iran. Frequent co-authors include Zhangang Xiao, Mingxing Li, Yueshui Zhao, Jing Shen, Xu Wu, Fukuan Du, Parham Jabbarzadeh Kaboli, Jing Li, Chi Hin Cho and Tao Yi.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.